HomeComparePTBS vs MRK

PTBS vs MRK: Dividend Comparison 2026

PTBS yields 2.63% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTBS wins by $10.79M in total portfolio value· pulled ahead in Year 2
10 years
PTBS
PTBS
● Live price
2.63%
Share price
$19.75
Annual div
$0.52
5Y div CAGR
82.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.85M
Annual income
$9,142,667.08
Full PTBS calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PTBS vs MRK

📍 PTBS pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTBSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTBS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTBS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTBS
Annual income on $10K today (after 15% tax)
$223.80/yr
After 10yr DRIP, annual income (after tax)
$7,771,267.02/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, PTBS beats the other by $7,762,670.31/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTBS + MRK for your $10,000?

PTBS: 50%MRK: 50%
100% MRK50/50100% PTBS
Portfolio after 10yr
$5.45M
Annual income
$4,576,390.43/yr
Blended yield
83.94%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PTBS
No analyst data
Altman Z
0.1
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTBS buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTBSMRK
Forward yield2.63%2.81%
Annual dividend / share$0.52$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR82.1%32.7%
Portfolio after 10y$10.85M$57.7K
Annual income after 10y$9,142,667.08$10,113.78
Total dividends collected$10.68M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PTBS vs MRK ($10,000, DRIP)

YearPTBS PortfolioPTBS Income/yrMRK PortfolioMRK Income/yrGap
1$11,179$479.45$11,213$373.04$34.00MRK
2← crossover$12,874$912.21$12,667$512.06+$207.00PTBS
3$15,563$1,787.80$14,439$708.14+$1.1KPTBS
4$20,331$3,678.10$16,640$988.16+$3.7KPTBS
5$29,931$8,177.19$19,432$1,394.07+$10.5KPTBS
6$52,514$20,488.00$23,057$1,992.90+$29.5KPTBS
7$117,366$61,175.93$27,889$2,894.79+$89.5KPTBS
8$358,269$232,687.15$34,518$4,286.29+$323.8KPTBS
9$1,592,176$1,208,828.66$43,912$6,494.35+$1.55MPTBS
10$10,846,296$9,142,667.08$57,714$10,113.78+$10.79MPTBS

PTBS vs MRK: Complete Analysis 2026

PTBSStock

Potomac Bancshares, Inc. operates as the bank holding company for Bank of Charles Town that provides various banking products and services to individuals and businesses. The company offers checking, savings, and individual retirement accounts; and certificates of deposit (CD). It also provides personal loans, including new and used vehicle, home equity, unsecured home improvement and personal, retail equipment, and lot loans, as well as loans secured by CD, and home equity lines of credit; commercial loans for building or office purchases, commercial real estate and construction, and production and administrative equipment purchases; lines of credit; mortgage, term, residential and commercial construction, commercial real estate, and agricultural loans; and credit and debit cards. In addition, the company offers Card Pay, cash management, merchant, financial planning, trust and estate, investment management, wealth management, full-service brokerage, retirement and insurance planning and products, asset allocation and management, and college planning services, as well as telephone, mobile, and online banking services. It operates through nine full-service offices and one loan production office located in the Eastern Panhandle of West Virginia, Washington County, Maryland, and Loudoun County, Virginia. The company was founded in 1871 and is based in Charles Town, West Virginia.

Full PTBS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PTBS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTBS vs SCHDPTBS vs JEPIPTBS vs OPTBS vs KOPTBS vs MAINPTBS vs JNJPTBS vs ABBVPTBS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.